VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Plaid, Verkada Quietly Line Up Banks for IPOs
Value Add VC/Pulse/IPO

Plaid, Verkada Quietly Line Up Banks for IPOs

Two well-capitalized infrastructure unicorns are separately testing the IPO waters, suggesting the reopened window extends beyond consumer brands and SpaceX-scale mega-deals.

By the Numbers

$8B (Feb 2026)
Plaid valuation
$13.4B
Plaid 2021 peak
$5.8B (Dec 2025)
Verkada valuation
$1B+ ARR
Verkada bookings
7,000+
Apps on Plaid
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 24, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Bloomberg reported fintech infrastructure company Plaid, valued at $8 billion in a February 2026 round, is in early talks with banks about a U.S. IPO

2

The Information separately reported Verkada, the enterprise physical-security platform valued at $5.8 billion in a CapitalG-led round, is also talking to banks

3

Verkada recently surpassed $1 billion in annualized bookings, a threshold companies often clear before pursuing a listing

4

Neither company has filed an S-1, but both talks land as consumer names like Jersey Mike's and Reformation actively price this same week, testing whether the window holds for infrastructure names next

TC

The VC Read · Trace's Take

Trace Cohen

Plaid and Verkada testing bank relationships quietly, while Jersey Mike's and Reformation do the loud roadshow thing, is exactly how sophisticated infra companies should play this market -- let the consumer names absorb the volatility first. If either files while the window's still open, expect a rush of enterprise SaaS peers to follow within weeks.

Unicorns → VC Exits →

Analysis

Two of the more closely watched private infrastructure companies are separately exploring public listings, according to reporting from Bloomberg and The Information. Bloomberg reported that Plaid, the fintech network whose APIs connect more than 7,000 apps -- including Venmo, Robinhood and Coinbase -- to consumer bank accounts, is in preliminary discussions with banks about a U.S. IPO. The talks follow Plaid's $8 billion valuation from a February 2026 funding round, a recovery from the $6.1 billion mark it hit in 2025 but still below its 2021 peak of $13.4 billion.

Separately, The Information reported that Verkada, the cloud-based enterprise security company known for cameras and access-control systems, is also talking to banks about a potential offering. Verkada was valued at $5.8 billion in a round led by Alphabet's CapitalG in December 2025, and the company has since crossed $1 billion in annualized bookings -- a milestone many private companies treat as a green light for IPO planning.

“Neither company has filed an S-1, and both remain in the earliest, most reversible stage of the process.”

Neither company has filed an S-1, and both remain in the earliest, most reversible stage of the process. But the fact that two infrastructure-heavy, non-consumer names are testing the market at the same time Jersey Mike's and Reformation are actively pricing this week suggests bankers see room for a broader mix of sectors in the current window, not just mega-cap names like SpaceX or consumer brands.

What to watch: whether either company files a confidential S-1 in the back half of 2026, and whether their eventual pricing echoes the conservative, below-rumor approach Jersey Mike's just took.

ShareXLinkedInEmail

More on

SpaceX →Plaid →

Reported by Value Add Pulse Analysis · First reported by Value Add Pulse · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com